{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Sterling%20Pharmaceutical%20Services%2C%20LLC","name":"Sterling Pharmaceutical Services, LLC","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-05T04:49:27.173Z"},"count":1,"matches":[{"id":"e73805a839ec6d4b","posted_date":"2022-10-04","letter_issue_date":"2022-09-27","company_name":"Sterling Pharmaceutical Services, LLC","issuing_office":"Division of Pharmaceutical Quality Operations III","subject":"CGMP/Finished Pharmaceuticals/Adulterated","canonical_url":"https://api.morvs.ai/fda-warning/e73805a839ec6d4b"}]}